Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Cyclo Therapeutics, Inc. Common Stock (CYTH)

Biological Products, (no Disgnostic Substances)

https://www.cyclodex.com

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.

6714 NW 16TH STREET, SUITE B
GAINESVILLE, FL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/09/2020

Market Cap

36,051,283

Shares Outstanding

28,590,000

Weighted SO

28,591,061

Total Employees

N/A

Upcoming Earnings

08/20/2024

Similar Tickers

ATNX --.--%

ATNX --.--%

MMNFF --.--%

MMNFF --.--%

LFCR --.--%

LFCR --.--%

LSDI --.--%

GHSI --.--%

AGRX --.--%

Beta

-0.3290

Last Div

0.0000

Range

0.89-2.12

Chg

0.0499

Avg Vol

57062

Mkt Cap

36051283

Exch

NASDAQ

Country

US

Phone

386 418 8060

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

31.8353

EV Multiple

-1.7943

P/FV

-7.0435

Div Yield %

0.0000

P/E

-1.7399

PEG

-0.2302

Payout

0.0000

Current Ratio

0.4528

Quick Ratio

0.4283

Cash Ratio

0.1141

DSO

26.9898

DIO

32.7908

Op Cycle

59.7805

DPO

525.1112

CCC

-465.3307

Gross Margin

-1.3692

Op Margin

-18.6810

Pretax Margin

-18.3129

Net Margin

-18.3129

Eff Tax Rate

-0.0002

ROA

-4.3954

ROE

102.6133

ROCE

4.1396

NI/EBT

1.0000

EBT/EBIT

0.9803

EBIT/Rev

-18.6810

Debt Ratio

0.6352

D/E

-0.5850

LT Debt/Cap

-0.0024

Total Debt/Cap

-1.4097

Int Coverage

-450104.6809

CF/Debt

-6.1285

Equity Multi

-0.9210

Rec Turnover

13.5237

Pay Turnover

0.6951

Inv Turnover

11.1312

FA Turnover

4.2300

Asset Turnover

0.2400

OCF/Share

-0.6413

FCF/Share

-0.6414

Cash/Share

0.0392

OCF/Sales

-16.2185

FCF/OCF

1.0001

CF Coverage

-6.1285

ST Coverage

-6.1539

CapEx Coverage

-7589.3992

Div&CapEx Cov

-7589.3992

P/BV

-7.0435

P/B

-7.0435

P/S

31.8353

P/E

-1.7399

P/FCF

-1.9626

P/OCF

-1.9646

P/CF

-1.9646

PEG

-0.2302

P/S

31.8353

EV Multiple

-1.7943

P/FV

-7.0435

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 23, 15:30 $HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of MKFG, CYTH, BRKH and CFB GlobeNewswire Inc. Nov 22, 22:40 $HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of CYTH, NAPA, MNTX and MARX GlobeNewswire Inc. Nov 20, 23:34 $HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of CYTH, VBFC, CFB and MKFG

Revenue Product Segmentation